Glucocorticoids Activate TGF-beta Induced PAI-1 and CTGF Expression in Rat Hepatocytes

Overview

Journal Comp Hepatol

Publisher Biomed Central

Specialty Gastroenterology

Date 2007 May 4

PMID 17474984

Citations 13

Authors

Lucia Wickert

Nicolas Chatain

Karin Kruschinsky

Axel M Gressner

Affiliations

Soon will be listed here.

Abstract

Background: In addition to the activation of hepatic stellate cells TGF-beta govern apoptosis and growth control of hepatocytes in liver injury. In non-parenchymal cells, TGF-beta induces plasminogen activator inhibitor 1 (PAI-1) and connective tissue growth factor (CTGF) expression, which are involved in extra cellular matrix formation. Both genes were also regulated by glucocorticoids, which in certain cases showed antagonistic effects to the TGF-beta-Smad 3 pathway. The purpose of our work was to investigate the influence of TGF-beta and dexamethasone on PAI-1 and CTGF expression and secretion in primary hepatocytes.

Results: By examining PAI-1 and CTGF mRNA and protein expression in cell lysates and cell-conditioned media under the influence of TGF-beta and dexamethasone, we analysed signalling pathways controlling their expression. TGF-beta and dexamethasone significantly co-induce PAI-1 and CTGF protein expression. On the other hand, we showed that TGF-beta diminished a glucocorticoid receptor dependent luciferase reporter signal in Hep-G2. Inhibition of Erk downstream activation decreased TGF-beta induced CTGF and PAI-1 expression to a basal level. PAI-1 was directly secreted by hepatocytes, whereas secretion of CTGF was retarded.

Conclusion: The data provide evidence that beside the TGF-beta-Smad 3 pathway CTGF and PAI-1 expression is additionally dependent on Erk activity in hepatocytes giving new insights into regulation of the profibrogenic proteins.

Citing Articles

CTGF (CCN2): a multifaceted mediator in breast cancer progression and therapeutic targeting.

Ghosh P, Dey A, Nandi S, Majumder R, Das S, Mandal M Cancer Metastasis Rev. 2025; 44(1):32.

PMID: 39945880 DOI: 10.1007/s10555-025-10248-4.

Glucocorticoid receptor: a harmonizer of cellular plasticity in breast cancer-directs the road towards therapy resistance, metastatic progression and recurrence.

Thakur D, Sengupta D, Mahapatra E, Das S, Sarkar R, Mukherjee S Cancer Metastasis Rev. 2024; 43(1):481-499.

PMID: 38170347 DOI: 10.1007/s10555-023-10163-6.

The Tumor Coagulome as a Transcriptional Target and a Potential Effector of Glucocorticoids in Human Cancers.

Racine F, Louandre C, Godin C, Chatelain B, Prekovic S, Zwart W Cancers (Basel). 2023; 15(5).

PMID: 36900323 PMC: 10001343. DOI: 10.3390/cancers15051531.

The Role of CTGF in Liver Fibrosis Induced in 3D Human Liver Spheroids.

Redensek Trampuz S, van Riet S, Nordling A, Ingelman-Sundberg M Cells. 2023; 12(2).

PMID: 36672237 PMC: 9857203. DOI: 10.3390/cells12020302.

The Association of Acute Phase Proteins in Stress and Inflammation-Induced T2D.

Speelman T, Dale L, Louw A, Verhoog N Cells. 2022; 11(14).

PMID: 35883605 PMC: 9321356. DOI: 10.3390/cells11142163.

References

Gressner A, Lahme B, Mannherz H, Polzar B . TGF-beta-mediated hepatocellular apoptosis by rat and human hepatoma cells and primary rat hepatocytes. J Hepatol. 1997; 26(5):1079-92. DOI: 10.1016/s0168-8278(97)80117-1. View

Bolkenius U, Hahn D, Gressner A, Breitkopf K, Dooley S, Wickert L . Glucocorticoids decrease the bioavailability of TGF-beta which leads to a reduced TGF-beta signaling in hepatic stellate cells. Biochem Biophys Res Commun. 2004; 325(4):1264-70. DOI: 10.1016/j.bbrc.2004.10.164. View

Dammeier J, Beer H, Brauchle M, Werner S . Dexamethasone is a novel potent inducer of connective tissue growth factor expression. Implications for glucocorticoid therapy. J Biol Chem. 1998; 273(29):18185-90. DOI: 10.1074/jbc.273.29.18185. View

Song C, Siok T, Gelehrter T . Smad4/DPC4 and Smad3 mediate transforming growth factor-beta (TGF-beta) signaling through direct binding to a novel TGF-beta-responsive element in the human plasminogen activator inhibitor-1 promoter. J Biol Chem. 1998; 273(45):29287-90. DOI: 10.1074/jbc.273.45.29287. View

McKay L, Cidlowski J . Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways. Endocr Rev. 1999; 20(4):435-59. DOI: 10.1210/edrv.20.4.0375. View

Song C, Tian X, Gelehrter T . Glucocorticoid receptor inhibits transforming growth factor-beta signaling by directly targeting the transcriptional activation function of Smad3. Proc Natl Acad Sci U S A. 1999; 96(21):11776-81. PMC: 18362. DOI: 10.1073/pnas.96.21.11776. View

Zhang L, Takahara T, YATA Y, Furui K, Jin B, Kawada N . Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells. J Hepatol. 1999; 31(4):703-11. DOI: 10.1016/s0168-8278(99)80351-1. View

Piek E, Heldin C, Ten Dijke P . Specificity, diversity, and regulation in TGF-beta superfamily signaling. FASEB J. 1999; 13(15):2105-24. View

Engel M, McDonnell M, Law B, Moses H . Interdependent SMAD and JNK signaling in transforming growth factor-beta-mediated transcription. J Biol Chem. 1999; 274(52):37413-20. DOI: 10.1074/jbc.274.52.37413. View

10.

Friedman S . Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem. 2000; 275(4):2247-50. DOI: 10.1074/jbc.275.4.2247. View

11.

Williams E, Gaca M, Brigstock D, Arthur M, Benyon R . Increased expression of connective tissue growth factor in fibrotic human liver and in activated hepatic stellate cells. J Hepatol. 2000; 32(5):754-61. DOI: 10.1016/s0168-8278(00)80244-5. View

12.

Irigoyen J, Munoz-Canoves P, Montero L, Koziczak M, Nagamine Y . The plasminogen activator system: biology and regulation. Cell Mol Life Sci. 2001; 56(1-2):104-32. PMC: 11146966. DOI: 10.1007/pl00000615. View

13.

Herrlich P . Cross-talk between glucocorticoid receptor and AP-1. Oncogene. 2001; 20(19):2465-75. DOI: 10.1038/sj.onc.1204388. View

14.

Gressner A, Weiskirchen R, Breitkopf K, Dooley S . Roles of TGF-beta in hepatic fibrosis. Front Biosci. 2002; 7:d793-807. DOI: 10.2741/A812. View

15.

Paradis V, Dargere D, Bonvoust F, Vidaud M, Segarini P, Bedossa P . Effects and regulation of connective tissue growth factor on hepatic stellate cells. Lab Invest. 2002; 82(6):767-74. DOI: 10.1097/01.lab.0000017365.18894.d3. View

16.

Chen Y, Blom I, Sa S, Goldschmeding R, Abraham D, Leask A . CTGF expression in mesangial cells: involvement of SMADs, MAP kinase, and PKC. Kidney Int. 2002; 62(4):1149-59. DOI: 10.1111/j.1523-1755.2002.kid567.x. View

17.

Periyasamy S, Sanchez E . Antagonism of glucocorticoid receptor transactivity and cell growth inhibition by transforming growth factor-beta through AP-1-mediated transcriptional repression. Int J Biochem Cell Biol. 2002; 34(12):1571-85. DOI: 10.1016/s1357-2725(02)00057-2. View

18.

Ma Y, Ryu J, Dulay A, Segal M, Guller S . Regulation of plasminogen activator inhibitor (PAI)-1 expression in a human trophoblast cell line by glucocorticoid (GC) and transforming growth factor (TGF)-beta. Placenta. 2002; 23(10):727-34. DOI: 10.1016/s0143-4004(02)90863-5. View

19.

Leask A, Holmes A, Black C, Abraham D . Connective tissue growth factor gene regulation. Requirements for its induction by transforming growth factor-beta 2 in fibroblasts. J Biol Chem. 2003; 278(15):13008-15. DOI: 10.1074/jbc.M210366200. View

20.

Li G, Wang S, Gelehrter T . Identification of glucocorticoid receptor domains involved in transrepression of transforming growth factor-beta action. J Biol Chem. 2003; 278(43):41779-88. DOI: 10.1074/jbc.M305350200. View